Effect of surfactant treatment on trends in bronchopulmonary dysplasia

被引：1
|
作者：
Phyu, P [1 ]
Tin, W [1 ]
Sinha, S [1 ]
机构：
[1] S Cleveland Hosp, Neonatol Unit, Middlesbrough, Cleveland, England
来源：
PEDIATRIC RESEARCH | 1999年 / 45卷 / 04期
关键词：
D O I：
10.1203/00006450-199904020-01870
中图分类号：
R72 [儿科学];
学科分类号：
100202 ;
摘要：
1854
引用
收藏
页码：314A / 314A
页数：1
相关论文
共 50 条
  • [31] Corticosteroids for the Treatment and Prevention of Bronchopulmonary Dysplasia
    Soll, Roger F.
    NEONATOLOGY, 2010, 98 (02) : 109 - 110
  • [32] Timing of postnatal corticosteroid treatment for bronchopulmonary dysplasia and its effect on outcomes
    Cuna, Alain
    Lewis, Tamorah
    Dai, Hongying
    Nyp, Michael
    Truog, William E.
    PEDIATRIC PULMONOLOGY, 2019, 54 (02) : 165 - 170
  • [33] 513 Timing of Surfactant Treatment in Extremely Premature Infants - Effects on Mortality and Development of Bronchopulmonary Dysplasia (BPD)
    T Farstad
    D Bratlid
    Pediatric Research, 2010, 68 : 262 - 263
  • [34] The efficacy of intratracheal administration of surfactant and budesonide combination in the prevention of bronchopulmonary dysplasia
    Gharehbaghi, Manizheh Mostafa
    Mhallei, Majid
    Ganji, Shalale
    Yasrebinia, Sanaz
    JOURNAL OF RESEARCH IN MEDICAL SCIENCES, 2021, 26 (01): : 31
  • [35] Genetic variants of surfactant proteins A, B, C, and D in bronchopulmonary dysplasia
    Pavlovic, J.
    Papagaroufalis, C.
    Xanthou, M.
    Liu, W.
    Fan, R.
    Thomas, N. J.
    Apostolidou, I.
    Papathoma, E.
    Megaloyianni, E.
    DiAngelo, S.
    Floros, J.
    DISEASE MARKERS, 2006, 22 (5-6) : 277 - 291
  • [36] Bronchopulmonary dysplasia: A review of the pulmonary sequelae in the post-surfactant era
    Haggie, Stuart
    Robinson, Paul
    Selvadurai, Hiran
    Fitzgerald, Dominic A.
    JOURNAL OF PAEDIATRICS AND CHILD HEALTH, 2020, 56 (05) : 680 - 689
  • [37] CHRONIC SURFACTANT DEFICIENCY AND RESTRICTED LUNG-FUNCTION IN BRONCHOPULMONARY DYSPLASIA
    OBLADEN, M
    STEVENS, P
    WAHN, U
    KLINISCHE PADIATRIE, 1984, 196 (04): : 233 - 233
  • [38] Polymorphisms of surfactant protein A genes and the risk of bronchopulmonary dysplasia in preterm infants
    Weber, B
    Borkhardt, A
    Stoll-Becker, S
    Reiss, I
    Gortner, L
    TURKISH JOURNAL OF PEDIATRICS, 2000, 42 (03) : 181 - 185
  • [39] Dexamethasone therapy in preterm infants with developing bronchopulmonary dysplasia: Effect on pulmonary surfactant disaturated phosphatidylcholine kinetics
    Cogo, P. E.
    Simonato, M.
    Toffolo, G. M.
    Stefanutti, G.
    Chierici, M.
    Cobelli, C.
    Ori, C.
    Carnielli, V. P.
    NEONATOLOGY, 2007, 91 (04) : 327 - 328
  • [40] EFFECT OF EXOGENOUS SURFACTANT ON THE DEVELOPMENT OF BRONCHOPULMONARY DYSPLASIA IN A BABOON HYALINE-MEMBRANE DISEASE-MODEL
    MAETA, H
    RAJU, TNK
    VIDYASAGAR, D
    BHAT, R
    ESTERLY, J
    MATSUDA, H
    SHIMADA, S
    KRUKENKAMP, IB
    SHANKLIN, DR
    CRITICAL CARE MEDICINE, 1990, 18 (04) : 403 - 409
12345